Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Free Access

Associations between Genetic Variants in the NOS1AP (CAPON) Gene and Cardiac Repolarization in the Old Order Amish

Post W.a, b · Shen H.c · Damcott C.c · Arking D.E.a, d · Kao W.H.L.b · Sack P.A.c · Ryan K.A.c · Chakravarti A.d · Mitchell B.D.c · Shuldiner A.R.c

Author affiliations

aDivision of Cardiology, Department of Medicine, Johns Hopkins University; bDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; cDivision of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland; dMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, and eGeriatrics Research and Education Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, Md., USA

Corresponding Author

Wendy Post, MD, MS

Division of Cardiology, Department of Medicine, Johns Hopkins University

Blalock 910H, 600 N. Wolfe Street

Baltimore, MD 21287 (USA)

Tel. +1 410 955 7376, Fax +1 443 287 0121, E-Mail wpost@jhmi.edu

Related Articles for ""

Hum Hered 2007;64:214–219

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

Background: Through a genome-wide association study, we discovered an association of the electrocardiographic QT interval with polymorphisms in the NOS1AP (CAPON) gene. The purpose of the current study was to replicate this association in the Old Order Amish. Methods: Four NOS1AP SNPs were selected that captured all major haplotypes in the region of interest (∼120 kb segment). Genotyping was completed in 763 subjects from the Heredity and Phenotype Intervention (HAPI) Heart Study. Association analyses were performed using a variance components methodology, accounting for relatedness of individuals. Results: Heritability of the QT interval was 0.50 ± 0.09 (p = 1.9 × 10–9). All four SNPs were common with a high degree of correlation between SNPs. Two of the four SNPs (pairwise r2 = 0.86) were significantly associated with variation in adjusted QT interval (rs1415262, p = 0.02 and rs10494366, p = 0.006, additive models for both). SNP rs10494366 explained 0.9% of QT interval variability, with an average genetic effect of 6.1 ms. Haplotypes that contained the minor allele for rs10494366 were associated with longer QT interval. Conclusions: This study provides further evidence that NOS1AP variants influence QT interval and further validates the utility of genome-wide association studies, a relatively new approach to gene discovery.

© 2007 S. Karger AG, Basel


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 12, 2007
Accepted: April 04, 2007
Published online: June 12, 2007
Issue release date: July 2007

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 2

ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)

For additional information: http://www.karger.com/HHE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.